Bio-Techne Corp (STU:TE1)
€ 69.5 0 (0%) Market Cap: 11.07 Bil Enterprise Value: 11.27 Bil PE Ratio: 80.74 PB Ratio: 5.63 GF Score: 95/100

Bio-Techne Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 01:15PM GMT
Release Date Price: €95 (+1.06%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

All right. Good morning, everybody. Welcome to Day 3 of the Healthcare Conference. I'm Tycho Peterson [from the health and] science team. It's my pleasure to introduce our next company this morning, Bio-Techne. Just a very quick reminder, there's a submit question function on the website, if people have questions they want answered. And with that, let me turn it over to Chuck.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Thanks, Tycho. Well, welcome, everybody. It's Bio-Techne presentation. I'm happy to be here. I think this is [eighth] invite I've had. The first one was to a near closet size room with 7 people way up in the hotel, and I hope there are hundreds of you out there this year. But if not, we're going to pretend there is. And we have a great story to tell you, and we'll get going.

First, safe harbor, of course, and we will have forward-looking statements. And like always, you want to reconcile the non-GAAP to the GAAP, get online on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot